Skip to main content
Premium Trial:

Request an Annual Quote

Lee Hartwell Wins Nobel Prize in Medicine

NEW YORK, Oct. 9 – Leland Hartwell, a co-founder of Rosetta Inpharmatics and director of the Fred Hutchinson Cancer Research Center in Seattle, was awarded The Nobel Prize in Physiology or Medicine for 2001, the Karolinksa Institute announced on Monday.

Hartwell, along with Paul Nurse and Timothy Hunt, both of London’s Imperial Cancer Research Fund, received the award for their discoveries of "key regulators of the cell cycle."

Hartwell founded Rosetta Inpharmatics with Stephen Friend and Leroy Hood in 1996. The company, acquired in May by Merck & Co. last month established a new business unit , Rosetta Biosoftware, to develop and sell new bioinformatics software for life science research.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.